Taking the mat is Judo Bio, an up-and-coming biotech armed with $100 million to develop oligonucleotide medicines targeting ...

Judo Bio, a biotechnology company pioneering oligonucleotide medicines delivered to the kidney, today announced that the company will present mechanistic and preclinical data that demonstrate the use ...

The Cambridge, Massachusetts-based biotech is using what it calls ligand-siRNA conjugates to reach drug targets in the kidney, which historically have been difficult to reach with RNA therapies.

Newly launched Judo Bio aims to develop ligand-siRNA conjugates through its Selectively Targeting RNA Into KidnEy (STRIKE) ...

Wales' most successful judoka, Natalie Powell, brings an end to a career which saw her win medals at every major championship ...

Japan's judo governing body decided on the first female head coach of its women's national team Wednesday, more than 10 years ...

Judo Bio, a biotechnology company pioneering oligonucleotide medicines delivered to the kidney, today announced the presentation of preclinical data that demonstrate the use of megalin receptors for ...

On the fourth day of the 2024 World Junior Judo Championship, crowds from all around the world gather in the capital of ...

A Coleraine judo club has recently returned from a championship in Belgium with an array of medals after competing against ...

ASTANA – Kazakhstan will hold the World Judo Championships in 2027, according to an agreement reached between Kazakh Minister ...

Judo athletes from around the world convened in San Jose on Saturday to remember the life of legendary San Jose State ...

Cambridge, USA-based biotech Judo Bio has announced the company’s launch and $100 million in initial financing, including ...